Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Cyclophosphamide (CY)-mediated immunoenhancement has been attributed to the inhibition of suppressor T-cell generation. In order to exert its effects on the immune system, metabolic activation of CY is required. The metabolite of CY responsible for its immunoenhancing properties are not known. Two reactive metabolites of CY which may inhibit suppressor T-cell generation are phosphoramide mustard and acrolein, compounds known to primarily bind to DNA and sulfhydryl groups, respectively. The objective of this study was to determine whether acrolein and/or phosphoramide mustard are capable of enhancing the immune response in a manner similar to CY. Administration of 100 mumol/kg of acrolein, i.v., to female C57BL/6 x C3H F1 mice 1 day before antigen exposure (sheep red blood cells) resulted in a 50% increase in the delayed-type hypersensitivity response (foot pad swelling). The Day 4 primary humoral immune response to sheep red blood cells was also increased by 88 and 60% after the administration of 30 and 100 mumol/kg acrolein 1 day before sensitization with sheep red blood cells. Exposure of splenocyte cultures to 3 x 10(-7) and 10(-6) M 4-hydroperoxy-CY or acrolein produced significant increases in the in vitro T-dependent antibody-forming cell response. In contrast, the antibody-forming cell response of cultures exposed to 3 x 10(-8) - 10(-4) M phosphoramide mustard did not increase above control levels. These results suggest that acrolein is responsible for the CY-induced enhancement of the immune response. Moreover, the enhancement may be produced by the binding of acrolein to sulfhydryl groups of molecules of cells required for the generation of suppressor T-cells.
Kawabata
T T
TT
Department of Pharmacology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0613.
White
K L
KL
D000171:Acrolein / Q000494:pharmacology*; D000447:Aldehydes / Q000494:pharmacology*; D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006968:Hypersensitivity, Delayed; D007109:Immunity / Q000187:drug effects*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D010752:Phosphoramide Mustards / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
D000447:Aldehydes; D010752:Phosphoramide Mustards; D013438:Sulfhydryl Compounds; C030090:phosphoramide mustard; D000171:Acrolein; D003520:Cyclophosphamide; C011272:perfosfamide